Since
1990, Aurora has been serving the global scientific research community
through the development of innovative laboratory solutions.
Headquartered in Vancouver, Canada, the company started manufacturing
analytical instrumentation based on a patented capacitively coupled
plasma emission technology. In 2000, Aurora became the first to develop a
non-radioactive, label-free technology for the study and high
throughput screening of ion channel and transporter targets. This
technology has been rapidly incorporated into many pharmaceutical drug
discovery pipelines and academic labs. Capitalizing on this expertise in
high throughput technologies, Aurora expanded its products to include
the VERSA series of automated liquid handling platforms aimed at the
life science, molecular diagnostics, and precision medicine fields. We
are committed to improving the quality of human and environmental health
by providing products and services that facilitate higher throughput
while enhancing quality, accuracy, and precision.
Since 2003, Aurora been the host of the annual Precision Medicine and
Ion Channel Retreat. This conference, designed to bring together
industry and leading academic researchers to share knowledge, exchange
ideas, and establish fruitful partnerships. This conference alternates
every year between Canada and China, attracting leading scientists from
around the world to engage in thought-provoking discussions on drug
discovery and personalized medicine. It allows Aurora and the community
to keep a pulse on cutting edge technology and innovative research.
In 2007, Aurora Biomed opened its Asia sales and services center to
facilitate expansion into the rapidly growing Asia market. To further
expand Aurora’s market reach, an active network of distributors based in
over 80 countries worldwide, providing sales and service support to
customers, was developed.